MURGY (MURGY) Stock Price & Analysis
MURGY (MURGY) rose 1.65% to USD 10.49 as of June 10, 2026 at 00:50 UTC, according to Nexqual real-time market data.
MURGY last closed at USD 10.32; the session ranged USD 10.47–10.53 on volume of 47,576 shares. Market capitalization is $67.12B, with a 52-week range of USD 10.09–14.41 (PNK). Source: Nexqual, June 10, 2026 at 00:50 UTC.
Key Statistics (as of June 10, 2026 at 00:50 UTC)
| Price | USD 10.49 |
|---|---|
| Change | ▲ 1.65% (up) |
| Previous Close | USD 10.32 |
| Open | USD 10.48 |
| Day Range | USD 10.47 – 10.53 |
| 52-Week Range | USD 10.09 – 14.41 |
| Volume | 47,576 shares |
| Market Cap | $67.12B |
| Exchange | PNK |
Technical Analysis (MURGY)
Nexqual's technical model rates MURGY "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 00:50 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.52 (neutral) |
| vs SMA50 | Below (USD 11.89) |
| MACD | -0.46 (negative) |
Analyst Ratings (MURGY)
Wall Street analysts rate MURGY "None" based on 2 analysts, with a mean price target of USD 13.44 (range USD 12.88–14), per Nexqual as of June 10, 2026 at 00:50 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 13.44 |
| High Target | USD 14 |
| Low Target | USD 12.88 |
| Buy / Hold / Sell | 1 / 1 / 0 |
Earnings (MURGY)
| EPS Estimate | USD 0.28 |
|---|---|
| Revenue Estimate | $18.13B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 1.57 vs est 0.32 ▲ beat |
| 2025-12-31 | USD 0.87 vs est 0.17 ▲ beat |
| 2025-09-30 | USD 1.8 vs est 0.34 ▲ beat |
| 2025-06-30 | USD 0.37 vs est 0.3 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Financials & Fundamentals (MURGY)
| Total Revenue | $61.35B |
|---|---|
| Revenue Growth (YoY) | -6.00% |
| Gross Margin | +36.11% |
| Operating Margin | +15.46% |
| Profit Margin | +10.97% |
| ROE | +19.85% |
| Debt / Equity | 21.72 |
| Current Ratio | 0.29 |
| Total Cash | $5.60B |
| Total Debt | $7.52B |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Financial Health Score (MURGY)
Nexqual rates MURGY's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 00:50 UTC.
| Growth | Weak — Revenue -2% YoY (annual), declining |
|---|---|
| Profitability | Solid — Gross margin 36%, operating 15% |
| Balance Sheet | Solid — $5.60B cash vs $7.52B debt |
| Cash Flow | Mixed — No data |
| Efficiency | Solid — ROE 20%, ROA 2.3% |
Ownership (MURGY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.14% |
| Shares Outstanding | 6.40B |
| Float | 6.37B |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Leadership (MURGY)
MURGY is led by Christoph Jurecka (age 51), CEO & Chairman of Management Board, per Nexqual as of June 10, 2026 at 00:50 UTC.
| CEO & Chairman of Management Board | Christoph Jurecka (age 51) |
|---|---|
| Member of Management Board & Labour Relations Director | Stefan Heinrich Golling (age 48) |
| CFO & Member of Management Board | Andrew James Buchanan (age 46) |
Major Backers & Investors (MURGY)
Notable institutional backers of MURGY include Aristotle Capital Management, LLC, according to Nexqual as of June 10, 2026 at 00:50 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Aristotle Capital Management, LLC | 0.12% |
Source: Nexqual, June 10, 2026 at 00:50 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SSREY | Swiss Re Ltd | USD 37.1 | ▲ 0.68% |
| ZURVY | Zurich Insurance Group Ltd | USD 35.07 | ▲ 1.33% |
| ALIZY | Allianz SE | USD 43.72 | ▲ 1.56% |
| HVRRY | Hannover Re | USD 43.82 | ▲ 1.18% |
| DBOEY | Deutsche Boerse AG | USD 28.34 | ▲ 0.18% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:50 UTC. This page is informational and not investment advice.